← Leaderboards
Subarna Sinha
Sri International
$205,424
Attributed
$410,847
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $277.3K · FY2017–19$500K$375K$250K$125K$0
'17
'18
'19
Funding mix
By agency
NIH$410,847 · 2
By mechanism
R21$410,847 · 2
Top collaborators
- Lidia C Sambucetti1 shared
- Yihui Shi1 shared
Most similar at Sri International
Same institution · by research overlap
- Adolf Pfefferbaum$63,604,427
- Paul D. Thomas$25,013,703
- Nurulain T Zaveri$24,519,975
- Natalie M Zahr$13,334,231
- Thomas S Kilduff$32,452,921
Others in their field
Other Emerging Leaders on “Inhibitor/Antagonist”
- Susan Abushakra · Alzheon, Inc.$27,500,000
- Alan D. Palkowitz · Indiana University Indianapolis$10,342,358
- Michael-Christopher Keogh · Epicypher, Inc.$6,845,336
- Terry Roemer · Prokaryotics, Inc.$6,530,728
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$6,175,581
- Aaron Esser-Kahn · University Of Chicago$5,799,408
Research focus
Inhibitor/AntagonistOverexpressionGenesGenotypeLeadNovel TherapeuticsDatabasesGene ExpressionGenomicsCancer CellIn VivoKnock-DownMalignant NeoplasmsMutationComputing MethodologiesData AnalysesData SetCancer TypeBaseGeneticCell DeathCell LineIn VitroPharmacology